Delivery of Therapy Guided by Molecular Imaging
Delivery of Therapy Guided by Molecular Imaging
Delivery of Therapy Guided by Molecular Imaging
•In USA, 1.5 M annual cases of myocardial infarction (MI), often complicated by heart failure, atrial fibrillation (A-fib) and ventricular tachycardia (VT).
•Prevalence of heart failure in US is projected to be 8 M by 2030
•Projected prevalence of A-fib by 2030 in US is 12.1 M
Catheter-based diagnostics for delivery of therapeutics to the heart is actively
Injection into the heart
Delivery of Therapy Guided by Molecular Imaging
Delivery of Therapy Guided by Molecular Imaging
Catheter-based diagnostics for delivery of therapeutics to the heart is actively performed for the treatment of heart disease
• Successful therapy depends on locating the ideal site for delivery of therapy
• Current methods of myocardial characterization and anatomical guidance are not adequate
• Our novel method is based on biological characterization of cardiac tissue as defined by uptake of molecularly-targeted radiotracers
Intra-Vascular Detection of Vulnerable Plaques
Intra-Vascular Detection of Vulnerable Plaques
Intra-Vascular Detection of Vulnerable Plaques
Catheter-based diagnostics for delivery of therapeutics to the heart is actively performed for the treatment of heart disease
• Successful therapy depends on locating the ideal site for delivery of therapy
• Current methods of myocardial characterization and anatomical guidance are not adequate
• Our novel method is based on
biological characterization of cardiac tissue as defined by uptake of molecularly-targeted radiotracers
vulnerable plaque
Intra-Vascular Detection of Vulnerable Plaques
Intra-Vascular Detection of Vulnerable Plaques
Say something interesting about your business here.